Advertisement

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Business

PharmaZell Picks Up Former Abbott Plant

by Rick Mullin
March 11, 2013 | A version of this story appeared in Volume 91, Issue 10

PharmaZell, a producer of active pharmaceutical ingredients, has acquired a manufacturing facility in Liestal, Switzerland, from Drug’On Pharma. The plant was previously owned by Abbott Laboratories. PharmaZell was formed in a management buyout of Noveon in 2006 and acquired by Ergon Capital Partners in 2011. Ergon subsequently combined the firm with Italy’s Farmabios. The new plant will add 150 m3 of reactor volume for multistep pharmaceutical chemical synthesis.

Article:

This article has been sent to the following recipient:

0 /1 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.